goBalto Company Overview

goBalto is a dedicated online drug development and manufacturing partnering website for the global pharmaceutical and biotech industries. The goBalto platform provides a quick and easy way to evaluate and manage potential drug development partners.

 

goBalto was established to help users identify and evaluate drug development service providers – including investigator sites, CROs, CMOs and consultants from around the globe. The goBalto platform provides an unmatched resource that helps companies quickly find and evaluate drug service providers, resulting in improved transparency, better decision making and greater cost savings in research and drug development.

 

By incorporating the latest in Web 2.0 technologies, goBalto’s platform enables service providers to distinguish their offerings by adding videos, images, customer testimonials and post referrals from members.

 

At launch more than 200 companies have subscribed and are already utilizing the goBalto platform. Industry leading biotech and pharmaceutical companies, such as Abbott Contract Manufacturing, Axio Research, Boehringer Ingelheim, CeeTox, Intas Biopharmaceuticals, Medrio, Quintiles, Syngene, Synteract and WuXi AppTec, are just a few of the companies already using the goBalto platform.

 

Based in San Francisco, CA, goBalto was founded in October 2008 by CEO Jae Chung. Prior to goBalto, Mr. Chung co-founded Celltrion in 2002, a leading contract biopharmaceutical group in Asia. Before starting Celltrion, Mr. Chung co-founded J. Stephens & Company Ventures and served as a strategy consultant at McKinsey & Company.

 

The goBalto website launched in April 2009 and currently has more than 7,000 service provider profiles available with more being added everyday from around the globe.